Further, the sharp increase of follicle-stimulating hormone (FSH) has also been confirmed to be another key causative factor for the development of central obesity as well as related metabolic abnormalities in menopausal women and OVX mouse models [3,4,5]. The gene discussed is BRD2; the disease is Abdominal obesity.